Priority Date: 08.04.11 (US 20110473513P)

MODULATION OF SCLERAXIS USING A DOMINANT NEGATIVE SCLERAXIS MUTANT WITH A BASIC DNA-BINDING DOMAIN DELETION

  • Application ID: EP11780011
  • Status: APPLICATION DEEMED TO BE WITHDRAWN

Applicant

Research organisation logo small
Research Organisation

Attorney

operating since 1908
Headquarter in Munich and 14 offices
active in Legal Services, IP Consulting, and IP-related Communication Service

Specialization

This EP application has the IPC combination A61, C07, and C12. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 126 others are specialized in this combination either. For a similar patent, they might be a good choice.

Timeline

  • 08.04.2011 - Priority Date (US 20110473513P)
  • 17.11.2011 - Publication A1 (WO2011140639)
  • 20.03.2013 - Publication A1 (EP2569433)

IPC Classification